1. Home
  2. ENTA vs FCAP Comparison

ENTA vs FCAP Comparison

Compare ENTA & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • FCAP
  • Stock Information
  • Founded
  • ENTA 1995
  • FCAP 1891
  • Country
  • ENTA United States
  • FCAP United States
  • Employees
  • ENTA N/A
  • FCAP N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • FCAP Savings Institutions
  • Sector
  • ENTA Health Care
  • FCAP Finance
  • Exchange
  • ENTA Nasdaq
  • FCAP Nasdaq
  • Market Cap
  • ENTA 109.0M
  • FCAP 102.2M
  • IPO Year
  • ENTA 2013
  • FCAP 1999
  • Fundamental
  • Price
  • ENTA $5.09
  • FCAP $32.15
  • Analyst Decision
  • ENTA Buy
  • FCAP
  • Analyst Count
  • ENTA 4
  • FCAP 0
  • Target Price
  • ENTA $17.25
  • FCAP N/A
  • AVG Volume (30 Days)
  • ENTA 503.4K
  • FCAP 1.9K
  • Earning Date
  • ENTA 02-18-2025
  • FCAP 01-24-2025
  • Dividend Yield
  • ENTA N/A
  • FCAP 3.63%
  • EPS Growth
  • ENTA N/A
  • FCAP N/A
  • EPS
  • ENTA N/A
  • FCAP 3.57
  • Revenue
  • ENTA $67,635,000.00
  • FCAP $41,997,000.00
  • Revenue This Year
  • ENTA $8.11
  • FCAP N/A
  • Revenue Next Year
  • ENTA N/A
  • FCAP N/A
  • P/E Ratio
  • ENTA N/A
  • FCAP $8.97
  • Revenue Growth
  • ENTA N/A
  • FCAP 2.23
  • 52 Week Low
  • ENTA $4.71
  • FCAP $26.03
  • 52 Week High
  • ENTA $17.80
  • FCAP $38.00
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 38.07
  • FCAP 51.96
  • Support Level
  • ENTA $4.94
  • FCAP $31.60
  • Resistance Level
  • ENTA $5.31
  • FCAP $32.50
  • Average True Range (ATR)
  • ENTA 0.32
  • FCAP 0.59
  • MACD
  • ENTA 0.11
  • FCAP 0.04
  • Stochastic Oscillator
  • ENTA 39.05
  • FCAP 60.81

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

Share on Social Networks: